本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

235.17
-29.7500-11.23%
成交量:198.57萬
成交額:4.66億
市值:155.66億
市盈率:18.15
高:257.53
開:256.25
低:228.56
收:264.92
52周最高:282.15
52周最低:186.05
股本:6,618.99萬
流通股本:6,553.95萬
量比:4.78
換手率:3.03%
股息:- -
股息率:- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率:118.78%
總資產收益率:9.58%
市淨率:9.39
市盈率(LYR):-53.23

資料載入中...

2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities